While the COVID-19 pandemic is far from over, the global disruption it has caused will drive many health care organizations to rethink their business model.
That’s the assessment of Ernst & Young health care leaders Pamela Spence and Jim Welch
Interview: Lessons Learned From The Pandemic And Five Strategies For Medtech’s Recovery
In an interview with Medtech Insight, two Ernst & Young health care leaders outline five trends for medtech companies to redefine their business models in response to COVID-19.
